Fig. 3From: Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinomaThe positive frequency of anti-SPP1 autoantibody in different clinical subgroups of ESCC patients. The clinical subgroups included sex (A), age (B), smoking (C), drinking (D), differentiation (E), clinical stage (F), lymphatic metastasis (G), distant metastasis (H), family tumor history (I). ESCC, esophageal squamous cell carcinomaBack to article page